Article

The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., Rockville, MD 20852, USA.
American journal of epidemiology (Impact Factor: 4.98). 03/2009; 169(7):901-8. DOI: 10.1093/aje/kwn404
Source: PubMed

ABSTRACT Although many epidemiologists use the National Death Index (NDI) as the "gold standard" for ascertainment of US mortality, high search costs per year and per subject for large cohorts warrant consideration of less costly alternatives. In this study, for 1995-2001 deaths, the authors compared matches of a random sample of 11,968 National Institutes of Health (NIH)-AARP Diet and Health Study subjects to the Social Security Administration's Death Master File (DMF) and commercial list updates (CLU) with matches of those subjects to the NDI. They examined how varying the lower limits of estimated DMF match probabilities (m scores of 0.60, 0.20, and 0.05) altered the benefits and costs of mortality ascertainment. Observed DMF/CLU ascertainment of NDI-identified decedents increased from 89.8% to 95.1% as m decreased from 0.60 (stringent) to 0.20 (less stringent) and increased further to 96.4% as m decreased to 0.05 (least stringent). At these same cutpoints, the false-match probability increased from 0.4% of the sample to 0.6% and then 2.3%. Limiting NDI cause-of-death searches to subjects found in DMF searches using less stringent match criteria, further supplemented by CLU vital status updates, improves vital status assessment while increasing substantially the cost-effectiveness of ascertaining mortality in large prospective cohort studies.

0 Followers
 · 
61 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Both short and long durations of sleep are associated with higher mortality, but little is known about the interrelationship between sleep and other modifiable factors in relation to mortality. In the National Institutes of Health-AARP Diet and Health Study (1995-1996), we examined associations between sleep duration and total, cardiovascular disease (CVD), and cancer mortality among 239,896 US men and women aged 51-72 years who were free of cancer, CVD, and respiratory disease. We evaluated the influence of moderate-to-vigorous physical activity, television viewing, and body mass index (BMI; weight (kg)/height (m)(2)) on the sleep-mortality association and assessed their combined association with mortality. During an average of 14 years of follow-up, we identified 44,100 deaths. Compared with 7-8 hours of sleep per day, both shorter and longer sleep durations were associated with higher total and CVD mortality. We found a greater elevation in CVD mortality associated with shorter sleep among overweight and obese people, suggesting a synergistic interaction between sleep and BMI. People in the unhealthy categories of all 4 risk factors (sleep <7 hours/day, moderate-to-vigorous physical activity ≤1 hour/week, television viewing ≥3 hours/day, and BMI ≥25) had significantly higher all-cause (relative risk (RR) = 1.42, 95% confidence interval (CI): 1.34, 1.52), CVD (RR = 1.90, 95% CI: 1.67, 2.17), and cancer (RR = 1.21, 95% CI: 1.09, 1.34) mortality. Short sleep duration may predict higher mortality, particularly CVD mortality, among overweight and obese people.
    American Journal of Epidemiology 10/2014; 180(10). DOI:10.1093/aje/kwu222 · 4.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. Recipients of liver transplantation (LT) for hepatocellular carcinoma (HCC) harbor an 8-20% risk of HCC recurrence. Single-center studies suggest that a period of waiting after HCC therapy may facilitate selection of patients at low risk for post-LT HCC recurrence and mortality. We evaluated whether longer waiting time after MELD prioritization for HCC predicts longer post-LT survival. Methods. In the United Network for Organ Sharing registry, we selected 2 groups registered for LT from March 2005 to March 2009: (1) HCC receiving MELD prioritization, and (2) non-HCC. Patients were stratified by MELD status at LT, a marker of time on the wait list after HCC MELD prioritization, and followed from LT until death or censoring through October 2012. We assessed predictors of post-LT survival and estimated the benefit of LT by comparing post-LT survival to the intention-to-treat (ITT) survival from registration. Results. The median MELDs at LT were 22 (HCC) and 24 (non-HCC). Increasing MELD at LT was independently associated with lower post-LT mortality in the HCC group (hazard ratio [HR]: 0.84; 95% confidence interval [CI]: 0.73-0.98) and higher post-LT mortality in the non-HCC group (HR: 1.20; 95% CI: 1.15-1.25). Compared to the HCC group, the non-HCC group had lower post-LT mortality (relative risk [RR]: 0.85; log-rank p<0.01) but higher ITT mortality (RR: 1.25; log-rank p<0.01), due to a 33 percentage-point lower probability of receiving LT. Conclusion. Longer waiting time before LT for HCC predicted longer post-LT survival in a national transplant registry. Delaying LT for HCC may reduce disparities in ITT survival and access to LT among different indications, thereby improving system utility and organ allocation equity in the overall pool of LT candidates. Liver Transpl , 2014. © 2014 AASLD.
    Liver Transplantation 09/2014; 20(9). DOI:10.1002/lt.23917 · 3.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several health agencies have issued guidelines promoting behaviors to reduce chronic disease risk; however, little is known about the impact of such guidelines, particularly on cancer incidence. The objective was to determine whether greater adherence to the American Cancer Society (ACS) cancer prevention guidelines is associated with a reduction in cancer incidence, cancer mortality, and total mortality. The NIH-AARP Diet and Health Study, a prospective cohort study of 566,401 adults aged 50-71 y at recruitment in 1995-1996, was followed for a median of 10.5 y for cancer incidence, 12.6 y for cancer mortality, and 13.6 y for total mortality. Participants who reported a history of cancer or who had missing data were excluded, yielding 476,396 subjects for analysis. We constructed a 5-level score measuring adherence to ACS guidelines, which included baseline body mass index, physical activity, alcohol intake, and several aspects of diet. Cox proportional hazards models were used to compute HRs and 95% CIs for the association of the adherence score with cancer incidence, cancer mortality, and total mortality. All analyses included fine adjustment for cigarette smoking. Among 476,396 participants, 73,784 incident first cancers, 16,193 cancer deaths, and 81,433 deaths from all causes were identified in the cohort. Adherence to ACS guidelines was associated with reduced risk of all cancers combined: HRs (95% CIs) for the highest compared with the lowest level of adherence were 0.90 (0.87, 0.93) in men and 0.81 (0.77, 0.84) in women. Fourteen of 25 specific cancer sites showed a reduction in risk associated with increased adherence. Adherence was also associated with reduced cancer mortality [HRs (95% CIs) were 0.75 (0.70, 0.80) in men and 0.76 (0.70, 0.83) in women] and reduced all-cause mortality [HRs (95% CIs) were 0.74 (0.72, 0.76) in men and 0.67 (0.65, 0.70) in women]. In both men and women, adherence to the ACS guidelines was associated with reductions in all-cancer incidence and the incidence of cancer at specific sites, as well as with reductions in cancer mortality and total mortality. These data suggest that, after accounting for cigarette smoking, adherence to a set of healthy behaviors may have considerable health benefits. This trial was registered at www.clinicaltrials.gov as NCT00340015. © 2015 American Society for Nutrition.
    American Journal of Clinical Nutrition 03/2015; 101(3). DOI:10.3945/ajcn.114.094854 · 6.92 Impact Factor

Preview

Download
0 Downloads
Available from